Marshall Wace, LLP Bristol Myers Squibb CO Call Options Transaction History

Marshall Wace, LLP

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2023 Aug 14, 2023	BUY	$63.71 - $70.74 $6.12 Million - $6.8 Million	96,100 New	96,100 $6.15 Million
Q4 2021 Feb 14, 2022	SELL	$53.63 - $62.52 $150,164 - $175,056	-2,800 Reduced 82.35%	600 $37,000
Q3 2021 Nov 15, 2021	BUY	$59.17 - $69.31 $201,178 - $235,654	3,400 New	3,400 $202,000

2,536

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $123B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

Stay updated on Marshall Wace, LLP with notifications on news.